Minimally invasive treatment of recurrent varicose veins with thrombotic complications using EVLA: A case report
 
 
More details
Hide details
1
BOGOMOLETS NATIONAL MEDICAL UNIVERSITY, KYIV, UKRAINE
 
 
Publication date: 2026-07-30
 
 
Corresponding author
Serhii Shchukin   

Department of Surgery, Anesthesiology and Intensive Care, Postgraduate Faculty, Bogomolets National Medical University, Kyiv, Ukraine, 121 Kharkivske Highway, 02091, Kyiv, Ukraine
 
 
Wiadomości Lekarskie 2026;(7):1700-1708
 
KEYWORDS
TOPICS
ABSTRACT
Aim:
To demonstrate the effectiveness and safety of endovenous laser ablation (EVLA) in the treatment of recurrent varicose veins of the lower extremities complicated by a floating thrombus in the popliteal vein in a patient with severe comorbidities.

Material and methods:
We present a clinical case of a 59-year-old male who complained of varicose veins and a burning sensation in the right lower limb. His medical history included bilateral great saphenous vein (GSV) removal (2003), type 2 diabetes mellitus, stage 4 chronic kidney disease, gout, and arterial hypertension. Duplex ultrasound revealed varicothrombophlebitis of the small saphenous vein (SSV) and a floating thrombus in the popliteal vein. Initial treatment consisted of oral anticoagulation with rivaroxaban, followed by EVLA of the SSV and ultrasound-guided sclerotherapy of tributaries.

Case report:
After anticoagulant therapy, partial recanalization of the SSV and thrombus lysis in the popliteal vein were observed. EVLA of the SSV was performed without complications. Anticoagulant therapy was continued in coordination with a hematologist. At 6-month follow-up, duplex ultrasound showed the SSV as a fibrotic cord (diameter 3–4 mm), with regression of symptoms of chronic venous insufficiency. Despite the patient’s high-risk profile, individualized management and careful monitoring allowed for the successful performance of a minimally invasive procedure.

Summary:
In selected high-risk patients with recurrent varicose disease complicated by thrombosis, EVLA may be considered following appropriate anticoagulant preparation. This case highlights the potential feasibility of an individualized and staged treatment approach in complex clinical settings.
eISSN:2719-342X
ISSN:0043-5147
Journals System - logo
Scroll to top